eli lilly glp 1 agonist FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic Eli Lilly to seek approval
Description
The apparent contradiction between these potential protective mechanisms and clinical observations of retinopathy worsening likely reflects the complex interplay between rapid metabolic changes and pre-existing vascular damage
The third international consensus definitions for sepsis and septic shock (Sepsis-3)
The FDAs approval of resmetirom changes the MASH drug development landscape for the better after years of failed programs 3
(2024, May)
Robert Kushner: It likely does, although it doesn't take away the physical exam and signs and symptoms and doing blood tests
2.3 Tissue-Specific Actions GLP-1 produces varied effects in various tissues via diverse signalling mechanisms
